A rare indication for lung transplantation - pulmonary alveolar microlithiasis: institutional experience of five consecutive cases

摘要

BackgroundPulmonary alveolar microlithiasis (PAM) is a rare lung disease caused by calcifications within the alveolar space. The only known effective treatment for an end-stage PAM is lung transplantation (LuTX).